Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
Ethnicity & Disease
|
September 12, 2018
Comparative Effectiveness of Coalitions Versus Technical Assistance for Depression Quality Improvement in Persons with Multiple Chronic Conditions
Benjamin Springgate, Lingqi Tang, Michael Ong, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis
Ealia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2019
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Rui Wang, Chan Gao, Megan Raymond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2015
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, et al.
British Journal of Cancer
|
March 13, 2020
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
Johann de Bono, Chia-Chi Lin, Li-Tzong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer
Eric Winquist, Sebastien J Hotte, Kim Chi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
February 21, 2024
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum
Fred Saad, Sebastien J Hotte, Krista Noonan, et al.
Future Oncology (London, England)
|
June 19, 2026
Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir
Michael Ong, Christopher Morash, Robert J Hamilton, et al.
European Urology Oncology
|
July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Pasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2014
Antitumor activity in RAS-driven tumors by blocking AKT and MEK
Anthony W Tolcher, Khurum Khan, Michael Ong, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
Ethnicity & Disease
|
September 12, 2018
Comparative Effectiveness of Coalitions Versus Technical Assistance for Depression Quality Improvement in Persons with Multiple Chronic Conditions
Benjamin Springgate, Lingqi Tang, Michael Ong, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis
Ealia Khosh Kish, Erind Dvorani, Refik Saskin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2019
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Rui Wang, Chan Gao, Megan Raymond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2015
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
Jean Sebastien Frenel, Suzanne Carreira, Jane Goodall, et al.
British Journal of Cancer
|
March 13, 2020
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
Johann de Bono, Chia-Chi Lin, Li-Tzong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer
Eric Winquist, Sebastien J Hotte, Kim Chi, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
February 21, 2024
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum
Fred Saad, Sebastien J Hotte, Krista Noonan, et al.
Future Oncology (London, England)
|
June 19, 2026
Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir
Michael Ong, Christopher Morash, Robert J Hamilton, et al.
European Urology Oncology
|
July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Pasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2014
Antitumor activity in RAS-driven tumors by blocking AKT and MEK
Anthony W Tolcher, Khurum Khan, Michael Ong, et al.
Page
of 12